Drugs / Growth Factors
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04330027 | Sep 2020 → Apr 2021 | shoulder impingement syndrome | Alexandria University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Growth Factors | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04330027 ↗ |
| Known as | L-GFs | “Platelet-derived lyophilized growth factors (L-GFs) use a standardized number of allogenic pathogen-free platelets instead of autologous platelets used in PRP as a source of...” PMID 36721157 ↗ Jan 2023 |
| Modality | Protein / enzyme biologic | “Platelet-derived lyophilized growth factors (L-GFs)” PMID 36721157 ↗ Jan 2023 |
| Route | Other | “group 2 received L-GF injection” PMID 36721157 ↗ Jan 2023 |